The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-κB Signaling
Open accessAbstract
The outcome of a viral infection is regulated in part by the complex coordination of viral and host interactions that compete for the control and optimization of virus replication. Severe acute respiratory syndrome coronavirus (SARS-CoV) intimately engages and regulates the host innate immune responses during infection. Using a novel interferon (IFN) antagonism screen, we show that the SARS-CoV proteome contains several replicase, structural, and accessory proteins that antagonize the IFN pathway. In this study, we focus on the SARS-CoV papain-like protease (PLP), which engages and antagonizes the IFN induction and NF-κB signaling pathways. PLP blocks these pathways by affecting activation of the important signaling proteins in each pathway, IRF3 and NF-κB. We also show that the ubiquitin-like domain of PLP is necessary for pathway antagonism but not sufficient by itself to block these pathways regardless of the enzymatic activity of the protease. The potential mechanism of PLP antagonism and its role in pathogenesis are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,344
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,676
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
Lau, S. K. P., Woo, P. C. Y., Li, K. S. M., Huang, Y., Tsoi, H.-W., Wong, B. H. L., Wong, S. S. Y., Leung, S.-Y., Chan, K.-H., & Yuen, K.-Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506735102 · Cited by 1,544
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
Theofilopoulos, A. N., Baccala, R., Beutler, B., & Kono, D. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115843 · Cited by 1,185
Recognition of pathogen-associated molecular patterns by TLR family
Akira, S., & Hemmi, H. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00228-6 · Cited by 1,150
Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems
García-Sastre, A., Egorov, A., Matassov, D., Brandt, S., Levy, D. E., Durbin, J. E., Palese, P., & Muster, T. (1998) · Virology · doi:10.1006/viro.1998.9508 · Cited by 1,000
Andrejeva, J., Childs, K. S., Young, D. F., Carlos, T. S., Stock, N., Goodbourn, S., & Randall, R. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407639101 · Cited by 992
Gale, M. J., Korth, M. J., Tang, N. M., Tan, S.-L., Hopkins, D. A., Dever, T. E., Polyak, S. J., Gretch, D. R., & Katze, M. G. (1997) · Virology · doi:10.1006/viro.1997.8493 · Cited by 810
Kopecky-Bromberg, S. A., Martínez-Sobrido, L., Frieman, M., Baric, R. A., & Palese, P. (2007) · Journal of Virology · doi:10.1128/jvi.01782-06 · Cited by 673
Self-citationBarretto, N., Jukneliene, D., Ratia, K., Chen, Z., Mesecar, A. D., & Baker, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15189-15198.2005 · Cited by 582
Self-citationFrieman, M., Yount, B., Heise, M., Kopecky-Bromberg, S. A., Palese, P., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.01012-07 · Cited by 507
Self-citationSymons, J. A., Alcamí, A., & Smith, G. L. (1995) · Cell · doi:10.1016/0092-8674(95)90076-4 · Cited by 490
The Ebola virus VP35 protein functions as a type I IFN antagonist
Basler, C. F., Wang, X., Mühlberger, E., Volchkov, V., Paragas, J., Klenk, H.-D., García-Sastre, A., & Palese, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220398297 · Cited by 478
Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation
Reid, S. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T., & Basler, C. F. (2006) · Journal of Virology · doi:10.1128/jvi.02349-05 · Cited by 463
Harcourt, B. H., Jukneliene, D., Kanjanahaluethai, A., Bechill, J., Severson, K. M., Smith, C. M., Rota, P. A., & Baker, S. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13600-13612.2004 · Cited by 462
Pushko, P., Parker, M., Ludwig, G. V., Davis, N. L., Johnston, R. E., & Smith, J. F. (1997) · Virology · doi:10.1006/viro.1997.8878 · Cited by 443
Self-citationWet markets—a continuing source of severe acute respiratory syndrome and influenza?
Webster, R. G. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15329-9 · Cited by 433
The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion
Levy, D. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00027-7 · Cited by 428 · cited 1×
“During virus entry and replication, the innate immune response machinery senses the invading virus and activates a cascade of signaling pathways that ultimately concludes with the translation of several hundred antiviral proteins to convert the intracellular environment into a suboptimal context for replication (32).”
BackgroundNarayanan, K., Huang, C., Lokugamage, K., Kamitani, W., Ikegami, T., Tseng, C.-T. K., & Makino, S. (2008) · Journal of Virology · doi:10.1128/jvi.02472-07 · Cited by 427
Ratia, K., Saikatendu, K. S., Santarsiero, B. D., Barretto, N., Baker, S. C., Stevens, R. C., & Mesecar, A. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510851103 · Cited by 414
Self-citationDevaraj, S. G., Wang, N., Chen, Z., Chen, Z., Tseng, M., Barretto, N., Lin, R., Peters, C. J., Tseng, C.-T. K., Baker, S. C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704870200 · Cited by 411
Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon
Cervantes-Barragan, L., Züst, R., Weber, F., Spiegel, M., Lang, K. S., Akira, S., Thiel, V., & Ludewig, B. (2007) · Blood · doi:10.1182/blood-2006-05-023770 · Cited by 397
Identification of a Novel Coronavirus in Bats
Poon, L. L. M., Chu, D. K. W., Chan, K. H., Wong, O. K., Ellis, T. M., Leung, Y. H. C., Lau, S. K. P., Woo, P. C. Y., Suen, K. Y., Yuen, K. Y., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2001-2009.2005 · Cited by 397
Park, M.-S., Shaw, M. L., Muñoz-Jordan, J., Cros, J. F., Nakaya, T., Bouvier, N., Palese, P., García-Sastre, A., & Basler, C. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.2.1501-1511.2003 · Cited by 378
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus
Yount, B., Curtis, K. M., Fritz, E. A., Hensley, L. E., Jahrling, P. B., Prentice, E., Denison, M. R., Geisbert, T. W., & Baric, R. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735582100 · Cited by 376
Self-citationWathelet, M. G., Orr, M., Frieman, M. B., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.00702-07 · Cited by 345
Self-citationHigh Fidelity of Murine Hepatitis Virus Replication Is Decreased in nsp14 Exoribonuclease Mutants
Eckerle, L. D., Lu, X., Sperry, S. M., Choi, L., & Denison, M. R. (2007) · Journal of Virology · doi:10.1128/jvi.01296-07 · Cited by 332
Ebola virus-like particles protect from lethal Ebola virus infection
Warfield, K. L., Bosio, C. M., Welcher, B. C., Deal, E. M., Mohamadzadeh, M., Schmaljohn, A., Aman, M. J., & Bavari, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237038100 · Cited by 244
Parisien, J.-P., Lau, J. F., Rodriguez, J. J., Sullivan, B. M., Moscona, A., Parks, G. D., Lamb, R. A., & Horvath, C. M. (2001) · Virology · doi:10.1006/viro.2001.0856 · Cited by 220
Severe Acute Respiratory Syndrome Coronavirus Phylogeny: toward Consensus
Gorbalenya, A. E., Snijder, E. J., & Spaan, W. J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.7863-7866.2004 · Cited by 220
Davis, N. L., Caley, I. J., Brown, K. W., Betts, M. R., Irlbeck, D. M., McGrath, K. M., Connell, M. J., Montefiori, D. C., Frelinger, J. A., Swanstrom, R., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.1.371-378.2000 · Cited by 200
Self-citationGraham, R. L., Sims, A. C., Brockway, S. M., Baric, R. S., & Denison, M. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.21.13399-13411.2005 · Cited by 192
Self-citationDowell, S. F., & Ho, M. S. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01177-6 · Cited by 180
Xiang, Y., Condit, R. C., Vijaysri, S., Jacobs, B., Williams, B. R. G., & Silverman, R. H. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.5251-5259.2002 · Cited by 177
Kash, J. C., Mühlberger, E., Carter, V., Grosch, M., Perwitasari, O., Proll, S. C., Thomas, M. J., Weber, F., Klenk, H.-D., & Katze, M. G. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.3009-3020.2006 · Cited by 175
Viruses know it all: new insights into IFN networks
Hengel, H., Koszinowski, U. H., & Conzelmann, K. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.05.004 · Cited by 163
Qian, X. Y., Alonso-Caplen, F. V., & Krug, R. M. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2433-2441.1994 · Cited by 158
Vaccinia Virus E3L Protein Is an Inhibitor of the Interferon (IFN)-Induced 2-5A Synthetase Enzyme
Rivas, C., Gil, J., Mělková, Z., Estéban, M., & Díaz‐Guerra, M. (1998) · Virology · doi:10.1006/viro.1998.9072 · Cited by 149
Zheng, D., Chen, G., Guo, B., Cheng, G., & Tang, H. (2008) · Cell Research · doi:10.1038/cr.2008.294 · Cited by 140
Connecting Mitochondria and Innate Immunity
McWhirter, S. M., tenOever, B. R., & Maniatis, T. (2005) · Cell · doi:10.1016/j.cell.2005.08.026 · Cited by 127
Involvement of the ubiquitin‐like domain of TBK1/IKK‐i kinases in regulation of IFN‐inducible genes
Ikeda, F., Hecker, C., Rozenknop, A., Nordmeier, R. D., Rogov, V. V., Hofmann, K., Akira, S., Dötsch, V., & Đikić, I. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601773 · Cited by 127
Shabman, R. S., Morrison, T. E., Moore, C. A., White, L., Suthar, M. S., Hueston, L., Rulli, N. E., Lidbury, B. A., Ting, J. P. ‐., Mahalingam, S., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01590-06 · Cited by 111
Mouse Hepatitis Coronavirus A59 Nucleocapsid Protein Is a Type I Interferon Antagonist
Ye, Y., Hauns, K., Langland, J., Jacobs, B. L., & Hogue, B. G. (2006) · Journal of Virology · doi:10.1128/jvi.01634-06 · Cited by 109
Hiscott, J. B., Grandvaux, N., Sharma, S., tenOever, B. R., Servant, M. J., & Lin, R. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1299.042 · Cited by 107
Aguilar, P. V., Adams, A. P., Wang, E., Kang, W., Carrara, A.-S., Anishchenko, M., Frolov, I. V., & Weaver, S. C. (2008) · Journal of Virology · doi:10.1128/jvi.02514-07 · Cited by 81
Cornell, C. T., Kiosses, W. B., Harkins, S., & Whitton, J. L. (2006) · Journal of Virology · doi:10.1128/jvi.02572-05 · Cited by 74
de Lang, A., Baas, T., Teal, T. H., Leijten, L. M. E., Rain, B., Osterhaus, A. D. M. E., Haagmans, B. L., & Katze, M. G. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030112 · Cited by 71
Balasuriya, U. B. R., Heidner, H. W., Hedges, J. F., Williams, J. C., Davis, N., Johnston, R. E., & MacLachlan, N. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10623-10630.2000 · Cited by 66
Self-citationSchoneboom, B., Lee, J. S., & Grieder, F. B. (2000) · Journal of Interferon and Cytokine Research · doi:10.1089/107999000312621 · Cited by 59
A Novel Ubiquitin-like Domain in IκB Kinase β Is Required for Functional Activity of the Kinase
May, M. J., Larsen, S. E., Shim, J., Madge, L. A., & Ghosh, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408579200 · Cited by 55
Measles Virus V Protein Inhibits p53 Family Member p73
Cruz, C. D., Palosaari, H., Parisien, J.-P., Devaux, P., Cattaneo, R., Ouchi, T., & Horvath, C. M. (2006) · Journal of Virology · doi:10.1128/jvi.02400-05 · Cited by 54
Exacerbated viral hepatitis in IFN-γ receptor-deficient mice is not suppressed by IL-12
Schijns, V. E. C. J., Wierda, C. M. H., van Hoeij, M. J. W., & Horzinek, M. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.815 · Cited by 53
Deubiquitinating Activity of the SARS-CoV Papain-Like Protease
Barretto, N., Jukneliene, D., Ratia, K. M., Chen, Z., Mesecar, A. D., & Baker, S. C. (2006) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-33012-9_5 · Cited by 40
Self-citationUbiquitin signals in the NF-κB pathway
Terzić, J., Marinovic‐Terzić, I., Ikeda, F., & Đikić, I. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350942 · Cited by 40
A follow-up study of 69 discharged SARS patients.
Han, Y., Geng, H., Feng, W., et al. (2003) · PubMed · Cited by 38
Antagonism between MyD88- and TRIF-dependent signals in B7RP-1 up-regulation
Zhou, Z., Hoebe, K. H. N., Du, X., Jiang, Z., Shamel, L., & Beutler, B. (2005) · European Journal of Immunology · doi:10.1002/eji.200525971 · Cited by 21
Cited by
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,787
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Metadata
- Authors
- Frieman, M., Ratia, K., Johnston, R. E., Mesecar, A. D., & Baric, R. S.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2009-07
- Volume
- 83
- Issue
- 13
- Pages
- 6689-6705
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2163448677
- Cited by
- 368
- References
- 59
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.